1. Academic Validation
  2. Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp

Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp

  • J Nat Prod. 2010 Sep 24;73(9):1529-37. doi: 10.1021/np100352e.
George E Chlipala 1 Megan Sturdy Aleksej Krunic Daniel D Lantvit Qi Shen Kyle Porter Steven M Swanson Jimmy Orjala
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Abstract

Material collected from a parkway in the city of Chicago afforded the isolation of a Nostoc species (UIC 10022A). The extract of this strain displayed significant inhibition of the 20S Proteasome as well as antiproliferative activity against HT29, MCF7, NCI-H460, and SF268 Cancer cell lines. A standardized dereplication protocol allowed for the rapid identification of three known (11-13) and nine new (1-9) chlorinated cylindrocyclophanes from less than 100 mg of organic extract. Scale-up isolation of 1-9 and 11-13 from a larger extract was guided by LC-UV-MS data. In addition, KBr enrichment of the culture media afforded the isolation of a brominated cylindrocyclophane (10). Biological evaluation of 1-5, 9, and 10-13 revealed a large range of activity against the 20S Proteasome and allowed the determination of preliminary structure-activity relationships of the cylindrocyclophane pharmacophore.

Figures